3. Tonix Pharmaceuticals Stock Prediction 2025: A Comprehensive Analysis
**Featured Picture** [Insert Image Here] Tonix Prescription drugs (NASDAQ: TNXP), a clinical-stage biopharmaceutical firm targeted on the event of progressive therapies for central nervous system (CNS) and immunological issues, has skilled a rollercoaster of inventory worth efficiency lately. After hitting a 52-week excessive of $3.70 in early 2023, the inventory has since plunged to its … Read more
